New Zealand’s health regulator Medsafe has approved the paediatric Pfizer vaccine against Covid-19 for children of age 5 to 12 years, the health ministry said in a statement.

• Is your trading account keeping up with what markets demand in 2026?
• Texmaco Rail Surges 15% on Rs 4,045 Cr South African Rail Order
• RVNL Shares Gain 2% on Securing Rs 221 Crore Order 
• Tata Power Slides 3.85% as Q4 Profit Drops, Revenue Misses
• Stocks Under F&O Ban: Steel Authority of India

The temporary approval is for two doses of the paediatric Pfizer Covid-19 vaccine, which can be given in at least 21 days break, the statement said. If the cabinet approves the vaccine, the paediatric Pfizer vaccine will be started in New Zealand by the end of January 2022, the health ministry added.